TWO SIGMA INVESTMENTS, LP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q2 2024$114,449
-36.7%
68,945
-12.7%
0.00%
Q1 2024$180,774
-8.2%
78,944
-20.7%
0.00%
Q4 2023$196,992
-16.2%
99,491
-45.0%
0.00%
-100.0%
Q3 2023$234,967
-70.3%
180,744
-63.0%
0.00%
-50.0%
Q2 2023$790,307
-11.2%
487,844
+16.7%
0.00%
-33.3%
Q1 2023$890,185
-22.0%
417,927
+35.5%
0.00%
-25.0%
Q4 2022$1,141,317
+284.3%
308,464
-22.8%
0.00%
+300.0%
Q3 2022$297,000
-2.9%
399,497
+1.6%
0.00%0.0%
Q2 2022$306,000
-54.6%
393,248
-47.2%
0.00%
-50.0%
Q1 2022$674,000
-39.9%
744,377
+455.7%
0.00%
-33.3%
Q3 2021$1,121,000
-7.0%
133,941
-25.1%
0.00%0.0%
Q2 2021$1,206,000
+54.6%
178,872
+51.6%
0.00%
+50.0%
Q1 2021$780,000
+369.9%
117,959
+198.8%
0.00%
Q4 2020$166,000
-2.9%
39,475
+40.3%
0.00%
-100.0%
Q2 2020$171,0000.0%28,136
-9.8%
0.00%0.0%
Q1 2020$171,000
-6.0%
31,203
+69.4%
0.00%0.0%
Q4 2019$182,000
+51.7%
18,415
-11.9%
0.00%
Q3 2019$120,000
+9.1%
20,908
+72.8%
0.00%
Q2 2019$110,000
-86.4%
12,101
-79.2%
0.00%
-100.0%
Q1 2019$809,000
-41.6%
58,311
-33.6%
0.00%
-40.0%
Q4 2018$1,385,000
+229.8%
87,801
+304.8%
0.01%
+400.0%
Q3 2018$420,00021,6880.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,922,570$19,053,0007.16%
DAFNA Capital Management LLC 1,114,000$11,040,0003.79%
RTW INVESTMENTS, LP 4,779,135$47,361,0001.79%
Kerrisdale Advisers, LLC 448,880$4,448,0001.57%
SPHERA FUNDS MANAGEMENT LTD. 805,000$7,978,0000.66%
Artal Group S.A. 1,300,000$12,883,0000.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,571,319$45,302,0000.11%
ALTRINSIC GLOBAL ADVISORS LLC 221,360$2,194,0000.09%
COWEN AND COMPANY, LLC 103,727$1,028,0000.09%
FRANKLIN STREET ADVISORS INC /NC 60,000$595,0000.07%
View complete list of PROQR THRAPEUTICS N V shareholders